Pharmaceuticals

Surge In Hypertension Prevalence Fueling The Growth Of The Market Due To Increased Lifestyle Risks And Demand For Effective Management Solutions Is Supporting Development Across The Candesartan Cilexetil Drug Market

May 18, 2026May 19, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Candesartan Cilexetil Drug Market Change Between 2026 And 2030?

The candesartan cilexetil drug market has experienced substantial growth in recent years. It is projected to expand from $1.65 billion in 2025 to $1.74 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 5.4%. Historically, this growth can be ascribed to factors including the increasing prevalence of hypertension, the clinical effectiveness of ARBs, a shift away from ACE inhibitors, the expansion of cardiovascular treatment guidelines, and a rising aging population.

The candesartan cilexetil drug market is projected for significant expansion in the coming years. Its size is anticipated to reach $2.15 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.5%. Factors driving this growth during the projection period include the rise in chronic cardiovascular conditions, wider penetration of generic drugs, greater adoption of combination medications, enhanced access in emerging economies, and the increase in preventive cardiovascular care. Key trends observed within the forecast period encompass the increasing application of angiotensin receptor blockers for hypertension, a rise in prescriptions for heart failure management, growing consumer demand for generic antihypertensive medications, an expansion in combination therapy options, and better patient adherence due to once-daily dosing regimens.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24183&type=smp

Which Drivers Are Advancing The Candesartan Cilexetil Drug Market Growth?

The increasing occurrence of hypertension is anticipated to drive expansion in the candesartan cilexetil drug market in the future. Hypertension, or high blood pressure, is a medical condition characterized by persistently elevated blood force against arterial walls, generally identified by readings of 130/80 mmHg or above. This condition is becoming more common due to factors like unhealthy dietary choices, insufficient physical activity, and elevated stress levels. The candesartan cilexetil drug aids in controlling hypertension by inhibiting angiotensin II, a hormone that narrows blood vessels, thereby relaxing them and lowering blood pressure. For example, in October 2024, data from the Centers for Disease Control and Prevention, a US-based government agency, showed that between August 2021 and August 2023, hypertension prevalence notably increased; it surged by 124.48% when transitioning from the 18–39 age group to the 40–59 age group, and by 36.38% from the 40–59 age group to individuals aged 60 and older. Consequently, the growing prevalence of hypertension is fueling demand for the candesartan cilexetil drug market.

How Is The Candesartan Cilexetil Drug Market Distributed Across Key Segments?

The candesartan cilexetil drug market covered in this report is segmented –

1) By Product Type: Tablets, Capsules, Other Product Types

2) By Indication: Hypertension, Heart Failure, Diabetic Nephropathy, Left Ventricular Hypertrophy

3) By Dosage Strength: 4 MG, 8 MG, 16 MG, 32 MG

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Healthcare Facilities

5) By Application: Adult, Children And Adolescent

Subsegments:

1) By Tablets: Immediate-Release Tablets, Extended-Release Tablets, Dispersible Tablets, Chewable Tablets

2) By Capsules: Hard Gelatin Capsules, Soft Gelatin Capsules, Modified-Release Capsules

3) By Other Product Types: Oral Suspensions, Injectable Formulations, Combination Drug Formulations

Which Trends Are Affecting The Candesartan Cilexetil Drug Market Framework?

Leading companies in the candesartan cilexetil drug market are prioritizing the development of innovative formulations such as treatments for high blood pressure, combination therapies with other drugs that lower blood pressure, and extended-release versions to enhance patient adherence and improve therapeutic outcomes. The management of hypertension involves the application of medications, adjustments to lifestyle, and other interventions aimed at reducing and controlling elevated blood pressure to lessen the likelihood of complications such as heart disease, stroke, and kidney damage. For instance, in March 2025, Scienture Inc., a US-based pharmaceutical company, obtained approval from the US Food & Drug Administration (USFDA) for its New Drug Application (NDA) for SCN-102, introduced as Arbli, which is a losartan potassium oral suspension (10 mg/mL). This angiotensin II receptor blocker (ARB) formulation presents an alternative for patients who encounter difficulty swallowing tablets, especially within pediatric and geriatric populations. This launch demonstrates the increasing interest in alternative dosage forms within the antihypertensive market and underscores the shift towards personalized, patient-friendly drug delivery systems.

Which Key Players Are Active In The Candesartan Cilexetil Drug Market?

Major companies operating in the candesartan cilexetil drug market are Merck & Co. Inc., Bayer AG, Novartis AG, AstraZeneca plc, GSK plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Sandoz Group AG, Viatris Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Limited, Cipla Limited, Zydus Lifesciences Ltd., Hetero Drugs Limited, Torrent Pharmaceuticals Limited, Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Limited, Oubari Pharmaceutical Co.

Access The Complete Candesartan Cilexetil Drug Market Report:

https://www.thebusinessresearchcompany.com/report/candesartan-cilexetil-drug-global-market-report

Which Area Represents The Largest Portion Of The Candesartan Cilexetil Drug Market?

North America was the largest region in the candesartan cilexetil drug market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the candesartan cilexetil drug market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Candesartan Cilexetil Drug Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24183&type=smp

Browse Through More Reports Similar to the Global Candesartan Cilexetil Drug Market 2026, By The Business Research Company

Cannabidiol Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabidiol-global-market-report

Benzodiazepine Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/benzodiazepine-drugs-global-market-report

Cytotoxic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/cytotoxic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795